A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
N/A
Crohn's disease (CD) is an incurable chronic inflammatory disorder of the g...
Status
Completed
Location
Peking University Third Hospital /ID# 242803
Start Date
2022-06-29
Trial ID
NCT05394805
The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases
N/A
The purpose of this study is to test the utility of PET/MRI in diagnosis an...
Status
Unknown
Location
Steffen Husby
Start Date
2018-10-18
Trial ID
NCT03640637
A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China
N/A
Bio-naive participants are defined as the participants who previously have ...
Status
Completed
Location
Sir Run Run Shaw Hospital, affiliated with Zhejiang University, School of Medicine